Hamartoma classification: Difference between revisions
Line 21: | Line 21: | ||
|CNS | |CNS | ||
| | | | ||
* Neurofibromatosis in von Recklinghausen disease | |||
* Neuroepithelial cells in tuberous sclerosis | |||
|- | |- | ||
|[[Lung]] | |[[Lung]] |
Revision as of 16:24, 10 September 2018
Hamartoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hamartoma classification On the Web |
American Roentgen Ray Society Images of Hamartoma classification |
Risk calculators and risk factors for Hamartoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Hamartomas may be classified into different types based on their location, such as: lung (most common), heart, hypothalamus, kidneys, or spleen. Other classifications can consider lesion class, dividing hamartomas into 4 different categories, such as: bone-forming, cartilage-forming, fiber-forming, and benign non–matrix-forming.[1]
Classification
Location
Based on the location, hamartomas can be classified into the following types:
Location | Type |
---|---|
Hypothalamus and
tuber cinereum |
|
CNS |
|
Lung |
|
Heart |
|
Kidneys |
|
Spleen |
|
Skin |
|
- Lung
- Endobronchial pulmonary hamartoma
- Parenchymal pulmonary hamartoma
- Heart
- Rhabdomyoma
- Hypothalamus
- Hypothalamic hamartoma
- Kidneys
- Angiomyolipoma
- Spleen
- Splenic hamartoma
Lesion class
Based on the lesion class, hamartomas can be classified into the following types:
- Bone-forming tumors
- Cartilage-forming tumors
- Fiber-forming tumors
- Nonossifying fibroma
- Fibrous dysplasia
- Mazabraud syndrome
- Benign non–matrix-forming tumors
References
- ↑ Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.